MINT MONO Sutures
Hans Biomed Corporation · Decision date Sep 18, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for MINT MONO Sutures, submitted by Hans Biomed Corporation of Yuseong-Gu, Korea, under 510(k) number K254238. The application was received on 12/29/2025 and decided on 09/18/2026. The device falls under the classification name Suture, Surgical, Absorbable, Polydioxanone, regulation number 878.4840, with the General & Plastic Surgery medical specialty and review panel. The classification product code is listed as NEW.
The submission was a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. SESE means FDA cleared the device as substantially equivalent to a predicate; it is not a PMA approval. The public record does not state the predicate device, the specific indications for use, or the materials and sizes covered, so those details remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254238
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Hans Biomed Corporation
- Product code
- NEW
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Suture, Surgical, Absorbable, Polydioxanone.
- Applicant
- Hans Biomed Corporation
- Product code
- NEW
- FDA device class
- 2
FDA decision timeline
K254238 received
Application receipt date recorded by FDA.
K254238 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hans Biomed Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Yuseong-Gu
Sources and methodology
- Original FDA record: K254238
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records